Morgan Stanley’s Talis Biomedical Corporation Common Stock TLIS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-87
| Closed | -$754 | – | 8093 |
|
|
2024
Q2 | $754 | Sell |
87
-548
| -86% | -$4.75K | ﹤0.01% | 7186 |
|
|
2024
Q1 | $5.56K | Sell |
635
-107
| -14% | -$936 | ﹤0.01% | 6867 |
|
|
2023
Q4 | $5.53K | Sell |
742
-1,519
| -67% | -$11.3K | ﹤0.01% | 6983 |
|
|
2023
Q3 | $13K | Sell |
2,261
-1,863
| -45% | -$10.8K | ﹤0.01% | 6630 |
|
|
2023
Q2 | $29.7K | Buy |
4,124
+67
| +2% | +$482 | ﹤0.01% | 6414 |
|
|
2023
Q1 | $29.8K | Buy |
4,057
+84
| +2% | +$617 | ﹤0.01% | 6477 |
|
|
2022
Q4 | $26.6K | Sell |
3,973
-1,319
| -25% | -$8.82K | ﹤0.01% | 6556 |
|
|
2022
Q3 | $54K | Sell |
5,292
-6,151
| -54% | -$62.8K | ﹤0.01% | 6375 |
|
|
2022
Q2 | $139K | Buy |
11,443
+1,423
| +14% | +$17.3K | ﹤0.01% | 6096 |
|
|
2022
Q1 | $212K | Sell |
10,020
-1,736
| -15% | -$36.7K | ﹤0.01% | 5889 |
|
|
2021
Q4 | $708K | Sell |
11,756
-9,218
| -44% | -$555K | ﹤0.01% | 5327 |
|
|
2021
Q3 | $1.97M | Sell |
20,974
-8,509
| -29% | -$798K | ﹤0.01% | 4600 |
|
|
2021
Q2 | $4.88M | Buy |
29,483
+28,331
| +2,459% | +$4.69M | ﹤0.01% | 3802 |
|
|
2021
Q1 | $222K | Buy |
+1,152
| New | +$222K | ﹤0.01% | 5605 |
|